本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

PharmaCyte Biotech, Inc.

1.19
+0.04003.48%
成交量:1.34萬
成交額:1.41萬
市值:820.08萬
市盈率:0.92
高:1.20
開:1.10
低:1.03
收:1.15
資料載入中...
2025/03/17

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/26

重要事件披露

Form 8-K - Current report
2024/12/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/12/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/17

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/05/31

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/03/18

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/25

重要事件披露

Form 8-K - Current report
2023/11/23

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/28

SEC問詢函

Form CORRESP - Correspondence
2023/09/18

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]